Effect of Biofeedback Activation on Balance in Osteoporotic Elderly

NCT ID: NCT07333989

Last Updated: 2026-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-02

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to investigate the effect of gluteus medius activation using electromyography (EMG) biofeedback combined with balance training on balance, physical performance, gluteus medius muscle activity, and quality of life in osteoporotic elderly patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Balance Problems Elderly (People Aged 65 or More)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gluteus medius isometric strengthening using EMG with traditional balance training

received 30 minutes of traditional balance training (functional strength, static and dynamic balance, and gait training) followed by 30 minutes of gluteus medius isometric strengthening using EMG biofeedback, three times per week, for four consecutive weeks.

Group Type EXPERIMENTAL

Electromyographic (EMG) biofeedback

Intervention Type DEVICE

a physical therapy intervention that uses auditory and visual feedback to control the contraction or relaxation of muscles. Repeated biofeedback training can induce motor learning of muscles. Biofeedback enhances the function of pelvic floor muscles by enhancing the force generation, correct timing, and coordination of the pelvic floor muscles. Electromyography Biofeedback is considered as a behavioural therapy training modality

Traditional balance training only

received balance training alone with the same frequency and duration.

Group Type ACTIVE_COMPARATOR

Balance training

Intervention Type OTHER

functional strength, static and dynamic balance, and gait training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electromyographic (EMG) biofeedback

a physical therapy intervention that uses auditory and visual feedback to control the contraction or relaxation of muscles. Repeated biofeedback training can induce motor learning of muscles. Biofeedback enhances the function of pelvic floor muscles by enhancing the force generation, correct timing, and coordination of the pelvic floor muscles. Electromyography Biofeedback is considered as a behavioural therapy training modality

Intervention Type DEVICE

Balance training

functional strength, static and dynamic balance, and gait training

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients included in this study met the following criteria:

1. Sixty patients of both sexes were diagnosed with osteoporosis confirmed by bone density test through Dual-energy X-ray absorptiometry (DEXA) scan (A T-score equal to or less than - 2.5) (Sheu and Diamond, 2016).
2. Their age ranged between 65 - 75 years.
3. Their BMI ranged between 25 - 29.9 kg/m2.
4. They had good mentality and cognitive function.

Exclusion Criteria

* The potential patients were excluded if they have one of the following criteria:

1. Patients with endocrine disorders likely to be related to metabolic bone disease, such as premature ovarian failure, hypogonadism, untreated hyperthyroidism, hyperparathyroidism, adrenal insufficiency or Cushing's syndrome.
2. Patients with active contagious skin conditions.
3. Patients with implant devices such as pacemaker or electrical prosthesis.
4. Any cardiopulmonary disorders.
5. Any neuromuscular disorders.
6. Any acute viral infection.
7. Patients with ascites or end stage liver or kidney failure.
8. Leg discrepancy.
Minimum Eligible Age

65 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mohamed Said Alsafy Alhamrawy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Said Alsafy Alhamrawy

Doctor

Responsibility Role SPONSOR_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohamed Alhamrawy

Role: CONTACT

+201013132649

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/005451

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.